News and Trends 20 Jun 2022
Investment in Hyperthermics’ process to turn biowaste into energy and proteins
Farvatn Private Equity and Måsøval Eiendom have invested in the Norwegian biotechnology company Hyperthermics AS. Through the investment, Farvatn and Måsøval now hold approximately 11% of the shares in Hyperthermics. Hyperthermics’ technology is based on hyperthermophilic bacteria, which degrade biomass, resulting in biogas and protein production. The high temperatures involved – 80ºC – speed up […]